The incidence, contributing etiopathogenetic factors, and prognostic s
ignificance of centrilobular necrosis were investigated in 270 hepatic
transplants to 215 immunosuppressed patients in whom 837 biopsies wer
e performed. Twenty-six (9.6%) grafts demonstrated centrilobular necro
sis in one or more biopsy specimens. The immunological, clinical, hist
opathological, and evolutionary features of this patient group (group
A) were compared with a control group of patients who had undergone 92
consecutive transplants with no necrosis (group B). Group A was young
er (p<0.01), had a higher average of warm and cold-ischemia time (p<0.
05), a higher incidence (p<0.001) and earlier appearance of acute reje
ction episodes (p<0.01), and a closer association with evolution to ch
ronic rejection (A: 53.8% vs B: 13.1%, p<0.001). Survival rates for gr
afts and patients with necrosis at 12 and 30 months were significantly
lower (p<0.001). The 26 grafts were distributed into three chronologi
cal subgroups according to when necrosis appeared: (1) First week - Al
l these grafts were lost (four through primary graft nonfunction and o
ne due to portal recurrent thrombosis); (2) Second week - seven grafts
with associated acute rejection, with three evolving to chronic rejec
tion; (3) After the second week (116+/-82 days)- five with isolated ne
crosis, two with associated acute rejection, four with associated duct
openia, and three with associated acute rejection and ductopenia. In 1
1 grafts the necrosis persisted and evolved to chronic rejection. In c
onclusion, these findings indicate that centrilobular necrosis is a hi
stopathological sign associated with poor prognosis in most hepatic gr
afts. Its association with greater donor-organ ischemia times and immu
nological changes may suggest a possible centrilobular ischemic etiolo
gy related to preservation problems and/or mediated by acute or chroni
c immune attack pathogenic mechanisms (endotheliitis and vasculapathy)
. (C) Journal of Hepatology.